News Related to Rheumatic Diseases

Related coverage linked through entity extraction aliases.

Advances in Precision Medicine and New Therapies for Psoriatic Arthritis

Jun 06, 2026

Recent research highlights advances in precision medicine for psoriatic arthritis, including a biopsy-driven treatment strategy that improved clinical outcomes and ongoing investigation into new biologic agents, combinations, and biomarker panels.

Spyre Therapeutics details ECCO presentations and SPY003 Phase 1 follow-up

Apr 17, 2026

Spyre Therapeutics announced ECCO 2026 presentations featuring 20-week follow-up from the Phase 1 SPY003 study and details of the SKYLINE-UC platform study. The company is also seeking to raise $403 million in a follow-on stock offering.